Artigos de revistas sobre o tema "Diffuse midline glioma (DMG)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Diffuse midline glioma (DMG)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Barron, Tara, Belgin Yalçın, Aaron Mochizuki, Evan Cantor, Kiarash Shamardani, Dana Tlais, Andrea Franson et al. "CNSC-01. GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i11. http://dx.doi.org/10.1093/neuonc/noad073.044.
Texto completo da fonteAl Sharie, Sarah, Dima Abu Laban, Jamil Nazzal, Shahad Iqneibi, Sura Ghnaimat, Abdallah Al-Ani e Maysa Al-Hussaini. "Midline Gliomas: A Retrospective Study from a Cancer Center in the Middle East". Cancers 15, n.º 18 (13 de setembro de 2023): 4545. http://dx.doi.org/10.3390/cancers15184545.
Texto completo da fonteIbdah, Haleem, Shervin Pejhan, Lee Ang, Cynthia Hawkins, Barbara Fisher, Joseph Megyesi e Maria MacDonald. "CEREBELLAR DIFFUSE MIDLINE GLIOMA, H3K27M ALTERED IN A FIFTY-FIVE-YEAR-OLD PATIENT". Neuro-Oncology Advances 5, Supplement_2 (1 de julho de 2023): i6. http://dx.doi.org/10.1093/noajnl/vdad071.026.
Texto completo da fonteChoi, Seonah, In-Ho Jung, Jaejoon Lim, Ju Hyung Moon, Eui Hyun Kim, Se Hoon Kim, Seok-Gu Kang e Jong Hee Chang. "PATH-06. SURVIVAL ANALYSIS FOR ADULT MIDLINE GLIOMA: DO ADULT MIDLINE GLIOMAS WITH THE H3 K27M MUTATION REALLY HAVE POOR PROGNOSIS?" Neuro-Oncology 24, Supplement_7 (1 de novembro de 2022): vii150—vii151. http://dx.doi.org/10.1093/neuonc/noac209.579.
Texto completo da fonteNakatogawa, Hirokazu, Hiroshi Kawaji, Nobuhide Hayashi, Junya Fukai, Noriyuki Kijima, Tomoko Shofuda, Ema Yoshioka et al. "10184-BT-14 CLINICAL FEATURE OF HEMISPHERIC GLIOMA WITH H3F3A, PEDIATRIC-TYPE HIGH GRADE GLIOMA, H3 K27-ALTERED, NEC AND DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT, CNS WHO GRADE 4". Neuro-Oncology Advances 5, Supplement_5 (1 de dezembro de 2023): v18—v19. http://dx.doi.org/10.1093/noajnl/vdad141.074.
Texto completo da fonteMorscio, Julie, Sandra Jacobs e Frederik De Smet. "DIPG-55. DISSECTING THE ECOSYSTEM OF PEDIATRIC DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.108.
Texto completo da fonteKnowles, Truman, Shejuan An, Tina Huang, Jin Qi e Amanda Saratsis. "DIPG-01. LIN28B EXPRESSION IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i12. http://dx.doi.org/10.1093/neuonc/noad073.048.
Texto completo da fonteKnowles, Truman, Shejuan An, Tina Huang, Jin Qi e Amanda Saratsis. "CSIG-11. LIN28B EXPRESSION IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 25, Supplement_5 (1 de novembro de 2023): v42. http://dx.doi.org/10.1093/neuonc/noad179.0167.
Texto completo da fonteKnowles, Truman, Shejuan An, Tina Huang, Jin Qi e Amanda Saratsis. "DIPG-02. LIN28B EXPRESSION IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.056.
Texto completo da fonteLarsen, Alexandra Giantini, Maricruz Rivera, David Pisapia, Sameer Farouk Sait, Matthias Karajannis, Jeffrey Greenfield e Mark Souweidane. "DIPG-44. DIFFUSE MIDLINE GLIOMA WITH EXTRACRANIAL METASTASIS". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i23. http://dx.doi.org/10.1093/neuonc/noad073.091.
Texto completo da fonteButterfield, Hannah E., Juliana Hofstatter Azambuja, Lisa Maurer, Dong Hu, Andrea F. Cruz, Matthew E. Halbert, Taylor A. Gatesman et al. "DIPG-85. MALT1 IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.138.
Texto completo da fonteMiguel Llordes, Gloria, Víctor Manuel Medina Pérez, Beatriz Curto Simón, Irene Castells-Yus, Silvia Vázquez Sufuentes e Alberto J. Schuhmacher. "Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma". Journal of Clinical Medicine 12, n.º 16 (12 de agosto de 2023): 5261. http://dx.doi.org/10.3390/jcm12165261.
Texto completo da fonteKlenner, Marbod, Pia Freidel, Mariella G. Filbin e Alexander Beck. "DIPG-39. New preclinical models for Diffuse Midline Glioma". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i27. http://dx.doi.org/10.1093/neuonc/noac079.096.
Texto completo da fonteTanaka, Kazuhiro, Hiroaki Nagashima, Shunsuke Yamanishi, Hirofumi Iwahashi, Tomoo Itoh e Takashi Sasayama. "MPC-16 CHARACTERISTICS AND PROGNOSTIC FACTORS OF H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA". Neuro-Oncology Advances 4, Supplement_3 (1 de dezembro de 2022): iii15—iii16. http://dx.doi.org/10.1093/noajnl/vdac167.057.
Texto completo da fonteTanaka, K., H. Nagashima, S. Yamanishi, T. Itoh e T. Sasayama. "P10.11.A CHARACTERISTICS OF DIFFUSE MIDLINE GLIOMA WITH H3 K27M MUTATION IN ADULTS". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii64. http://dx.doi.org/10.1093/neuonc/noad137.209.
Texto completo da fonteNakatogawa, Hirokazu, Hiroshi Kawaji, Nobuhide Hayashi, Junya Fukai, Noriyuki Kijima, Tomoko Shofuda, Ema Yoshioka et al. "MPC-15 CLINICAL FEATURE OF NON-MIDLINE GLIOMA WITH H3F3A GENE MUTATION". Neuro-Oncology Advances 4, Supplement_3 (1 de dezembro de 2022): iii15. http://dx.doi.org/10.1093/noajnl/vdac167.056.
Texto completo da fonteHolliday, Holly, Anahid Ehteda, Aaminah Khan, Brian Krug, Jourdin R. C. Rouaen, Nisitha Jayatilleke, Chelsea Mayoh et al. "DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i18. http://dx.doi.org/10.1093/neuonc/noac079.063.
Texto completo da fonteWillimas, E. A., P. K. Brastianos, H. Wakimoto, S. Santagata, D. P. Cahill e T. A. Juratli. "P04.04.A A comprehensive genomic study of 390 H3F3A-mutant pediatric-type diffuse high-grade gliomas WHO CNS grade 4". Neuro-Oncology 24, Supplement_2 (1 de setembro de 2022): ii35—ii36. http://dx.doi.org/10.1093/neuonc/noac174.119.
Texto completo da fonteWilliams, Erik, Priscilla Brastianos, Hiroaki Wakimoto, Sandro Santagata, Daniel Cahill e Tareq Juratli. "PATH-08. A COMPREHENSIVE GENOMIC STUDY OF 390 H3F3A-MUTANT PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMAS WHO CNS GRADE 4". Neuro-Oncology 24, Supplement_7 (1 de novembro de 2022): vii151. http://dx.doi.org/10.1093/neuonc/noac209.581.
Texto completo da fonteUchida, Eita, Yukitomo Ishi, Jun Watanabe, Hiam Abdala-Valencia, Benjamin Singer, Samantha Gadd e Rintaro Hashizume. "DIPG-82. RADIOSENSITIZATION WITH RAD52 INHIBITION IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.135.
Texto completo da fonteLiapodimitri, Athanasia, Kayleigh Lunsford, Ashley R. Tetens, Jordyn Craig-Schwartz, Farhad Vesuna, Venu Raman e Michael A. Koldobskiy. "DIPG-64. UNRAVELING H3K27M INTERACTIONS IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.117.
Texto completo da fonteBalakrishnan, Illango, Krishna Madhavan, Angela Pierce, Sujatha Venkataraman e Rajeev Vibhakar. "EXTH-49. A NOVEL THERAPEUTIC ANTIBODY TARGETING DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 24, Supplement_7 (1 de novembro de 2022): vii220. http://dx.doi.org/10.1093/neuonc/noac209.847.
Texto completo da fonteBoult, Jessica, Diana Carvalho, Ketty Kessler, Maria Vinci, Elisabet Fernandez, Lynn Bjerke, Mariama Fofana et al. "IMG-09. Characterisation of a panel ofin vivo models of paediatric-type diffuse high-grade glioma (PDHGG) using magnetic resonance imaging". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i78. http://dx.doi.org/10.1093/neuonc/noac079.285.
Texto completo da fonteGallitto, Matthew, Genesis Los De Santos, Hong-Jian Wei, Xu Zhang, Zhiguo Zhang e Cheng-Chia Wu. "DIPG-41. CONVECTION ENHANCED DELIVERY-MEDIATED RADIOSENSITIZATION FOR DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.094.
Texto completo da fonteCartaxo, Rodrigo, Edwin Nieblas-Bedolla, Michael Niculcea, Madeline Miclea, Ruby `. Siada, Kallen Schwark, Sunjong Ji et al. "HGG-52. MULTI-INTEGRIN TARGETING EFFECTIVELY SUPPRESSES DIFFUSE MIDLINE GLIOMA MIGRATION". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.336.
Texto completo da fonteDamodharan, Sudarshawn, Jeffrey Helgager e Diane Puccetti. "INNV-13. INDOLENT H3 K27-ALTERED DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 24, Supplement_7 (1 de novembro de 2022): vii143. http://dx.doi.org/10.1093/neuonc/noac209.553.
Texto completo da fontePaul, Sonal, Nitin M. Gadgil e Chetan Chaudhari. "Diffuse Midline Glioma (H3K27M mutant) in Adult: A Diagnostic Challenge". Annals of Pathology and Laboratory Medicine 7, n.º 10 (29 de outubro de 2020): C123–127. http://dx.doi.org/10.21276/apalm.2851.
Texto completo da fonteTsoli, Maria, Caitlin Ung, Dannielle H. Upton, Pooja Venkat, Antonietta Salerno, Ruby Pandher, Chelsea Mayoh, Orazio Vittorio e David S. Ziegler. "DIPG-35. OVERCOMING THE BLOOD-BRAIN BARRIER CHALLENGE IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.088.
Texto completo da fonteNduom, Edjah K., John Glod, Desmond A. Brown, Margaret Fagan, Mahalia Dalmage, John Heiss, Seth M. Steinberg, Cody Peer, William D. Figg e Sadhana Jackson. "Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis". PLOS ONE 18, n.º 9 (8 de setembro de 2023): e0291068. http://dx.doi.org/10.1371/journal.pone.0291068.
Texto completo da fonteCiani, Ludovica, Sandra Laternser, Bettina Kritzer, Kerstin Hasler, Justyna M. Przystal, Mohana R. Velagapudi, Marta M. Alonso, Marta Zalacain, Sabine Müller e Javad Nazarian. "DIPG-22. TRIPTOLIDE AS A POTENTIALLY PROMISING THERAPY FOR DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i17. http://dx.doi.org/10.1093/neuonc/noad073.069.
Texto completo da fonteNeyazi, Sina, Pruthvi Gowda, Stephen C. Frederico, Cuong M. Nguyen, Maria C. Trissal, Erika P. Portero, John-Paul Haley-Read et al. "DIPG-14. METABOLIC REPROGRAMMING AS A RESISTANCE MECHANISM IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.067.
Texto completo da fonteDamodharan, Sudarshawn, Peter Favreau, Connie Lebakken e Mahua Dey. "BIOL-19. DIFFUSE MIDLINE GLIOMA CEREBRAL ORGANOID MODEL AND MULTIOMICS CHARACTERIZATION". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i10. http://dx.doi.org/10.1093/neuonc/noad073.038.
Texto completo da fonteKnowles, Truman, Tina Huang, Shejuan An, Jin Qi e Amanda Muhs Saratsis. "134 LIN28B as a Novel Therapeutic Target in Diffuse Midline Glioma". Neurosurgery 70, Supplement_1 (abril de 2024): 28–29. http://dx.doi.org/10.1227/neu.0000000000002809_134.
Texto completo da fonteMobark, Nahla Ali, Musa Alharbi, Yasser S. Bayoumi, Aymn Albanyan, Ali Abdullah O. Balbaid, Wael abdel Rahman Aljabarat e Malak Abedalthagafi. "DIPG-35. Personalized treatment for molecularly heterogeneous Diffuse midline glioma, H3 k27-altered Paediatric case". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i26. http://dx.doi.org/10.1093/neuonc/noac079.092.
Texto completo da fonteTzaridis, Theophilos, Tanja Eisemann, Augusto Faria Andrade, Jennifer L. Hope, Oren Becher, Nada Jabado, Linda M. Bradley, Peter Adams e Robert Wechsler-Reya. "Abstract 2648: CD155 regulates cell growth and immune evasion in diffuse midline glioma". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 2648. http://dx.doi.org/10.1158/1538-7445.am2024-2648.
Texto completo da fonteJackson, Sadhana, John Glod, Cody Peer, William Figg, Mahalia Dalmage e Desmond Brown. "TRLS-02. FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMACOKINETICS OF DIFFUSE MIDLINE GLIOMA USING INTRATUMORAL MICRODIALYSIS". Neuro-Oncology 25, Supplement_1 (1 de junho de 2023): i79. http://dx.doi.org/10.1093/neuonc/noad073.305.
Texto completo da fonteMessinger, Dana, Micah Harris, Jessica Cummings, Chase Thomas, Tao Yang, Stefan Sweha, Rinette Woo et al. "CSIG-09. THERAPEUTIC TARGETING OF PRENATAL PONTINE ID1 SIGNALING IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 24, Supplement_7 (1 de novembro de 2022): vii40. http://dx.doi.org/10.1093/neuonc/noac209.158.
Texto completo da fonteTanaka, Shota, Shunsaku Takayanagi, Yuki Shinya, Mariko Kawashima, Masahiro Shin, Hirofumi Nakatomi e Nobuhito Saito. "DIPG-17. BIOPSY-PROVEN DIFFUSE MIDLINE GLIOMA IN ADOLESCENTS AND YOUNG ADULTS". Neuro-Oncology 22, Supplement_3 (1 de dezembro de 2020): iii290. http://dx.doi.org/10.1093/neuonc/noaa222.067.
Texto completo da fonteTomita, Yusuke, Nozomu Takata e Oren Becher. "10084-TB-2 IN VITRO CHARACTERIZATION OF COMBINATION THERAPY IN GENETICALLY-ENGINEERED MURINE DIFFUSE MIDLINE GLIOMA MODELS". Neuro-Oncology Advances 5, Supplement_5 (1 de dezembro de 2023): v10. http://dx.doi.org/10.1093/noajnl/vdad141.038.
Texto completo da fonteKnowles, Truman, Tina Huang, Jin Qi, Shejuan An, Noah Burket, Scott Cooper, Javad Nazarian e Amanda M. Saratsis. "LIN28B and Let-7 in Diffuse Midline Glioma: A Review". Cancers 15, n.º 12 (19 de junho de 2023): 3241. http://dx.doi.org/10.3390/cancers15123241.
Texto completo da fontePal, Sharmistha, Jakub P. Kaplan, Sylwia A. Stopka, Michael S. Regan, Bradley R. Hunsel, Benjamin H. Kann, Nathalie Y. R. Agar et al. "DDRE-32. THERAPEUTIC TARGETING OF A NOVEL METABOLIC ADDICTION IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology Advances 3, Supplement_1 (1 de março de 2021): i13. http://dx.doi.org/10.1093/noajnl/vdab024.054.
Texto completo da fonteFindlay, Izac J., Geoffry N. De Iuliis, Ryan J. Duchatel, Evangeline R. Jackson, Nicholas A. Vitanza, Jason E. Cain, Sebastian M. Waszak e Matthew D. Dun. "Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies". Oncogene 41, n.º 4 (10 de novembro de 2021): 461–75. http://dx.doi.org/10.1038/s41388-021-02102-y.
Texto completo da fonteOza, Viral, Shilpa Sampathi, Yelena Chernyavskava, Kenan Flores e Jessica Blackburn. "Abstract 1126: Extracellular vesicle mediated radioresistance in H3K27M-diffuse midline glioma". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 1126. http://dx.doi.org/10.1158/1538-7445.am2024-1126.
Texto completo da fontePatel, Palak, Bharti Kukreja, Brian Kalish, Sanja Pajovic e Cynthia Hawkins. "TMIC-77. UNVEILING THE DEPTHS: EXPLORING DIFFUSE MIDLINE GLIOMA, TUMORIGENESIS, AND RADIATION RESISTANCE". Neuro-Oncology 25, Supplement_5 (1 de novembro de 2023): v295—v296. http://dx.doi.org/10.1093/neuonc/noad179.1142.
Texto completo da fontedu Chatinier, Aimée, Michaël H. Meel, Arvid I. Das, Dennis S. Metselaar, Piotr Waranecki, Marianna Bugiani, Marjolein Breur et al. "MODL-16. Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i172. http://dx.doi.org/10.1093/neuonc/noac079.639.
Texto completo da fonteMoloney, Sam, Vickyanne Carruthers, Melissa J. Davis, Dharmesh D. Bhuva, Cristina Mignone, Susan Singh, Rebecca E. Gardiner, Santosh Valvi, David D. Eisenstat e Jordan R. Hansford. "DIPG-54. PREDICTING EARLY DEATH IN DIFFUSE MIDLINE GLIOMA". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.107.
Texto completo da fonteFrederico, Stephen C., Sina Neyazi, Pruthvi Gowda, Cuong Nguyen, Maria Trissal, Erika P. Portero, John-Paul Haley-Read et al. "Revealing and targeting metabolic drivers contributing to treatment escape in diffuse midline glioma." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): 10038. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.10038.
Texto completo da fonteDi Ruscio, Valentina, Giada Del Baldo, Francesco Fabozzi, Maria Vinci, Antonella Cacchione, Emmanuel de Billy, Giacomina Megaro, Andrea Carai e Angela Mastronuzzi. "Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle". Diagnostics 12, n.º 9 (25 de agosto de 2022): 2064. http://dx.doi.org/10.3390/diagnostics12092064.
Texto completo da fonteParthasarathy, Akhila, Marc Garcia-Moure, Jiasen He, Dong Ho Shin, Andrew G. Gillard, Andres Lopez-Rivas, Lethan A. Hampton et al. "DIPG-45. TARGETING HYPERACETYLATION IN PEDIATRIC DIFFUSE MIDLINE GLIOMAS USING ONCOLYTIC ADENOVIRUSES". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.098.
Texto completo da fonteGestrich, Catherine, Kristina Grieco, Hart Lidov, Keith Ligon, Sandro Santagata, Kee Kiat Yeo, Sanda Alexandrescu e David Meredith. "DIPG-44. H3K27-altered diffuse midline gliomas with secondary driver molecular alterations". Neuro-Oncology 24, Supplement_1 (1 de junho de 2022): i28. http://dx.doi.org/10.1093/neuonc/noac079.101.
Texto completo da fonte